Xiang X - Search Results

1

Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.

Chen B, Li H, Liu C, Xiang X, Wang S, Wu A, Shen Y, Li G. Chen B, et al. Among authors: xiang x. PLoS One. 2020 Nov 10;15(11):e0242173. doi: 10.1371/journal.pone.0242173. eCollection 2020. PLoS One. 2020. PMID: 33170901 Free PMC article.

2

[Effect of Suture Lines on Lung Adenocarcinoma Cell in vitro.].

Ye L, Huang Y, Li G, Jin Q, Duan L, Xiang X, Guo G. Ye L, et al. Among authors: xiang x. Zhongguo Fei Ai Za Zhi. 2009 Sep 20;12(9):961-4. doi: 10.3779/j.issn.1009-3419.2009.09.004. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719192 Free article. Chinese.

3

Open resection for lung cancer in right upper lobe.

Guo G, Li H, Li GF, Chen N, Ma QL, Xiang XD. Guo G, et al. J Thorac Dis. 2013 Dec;5(6):862-3. doi: 10.3978/j.issn.2072-1439.2013.12.01. J Thorac Dis. 2013. PMID: 24409367 Free PMC article.

4

In vitro study on blocking mTOR signaling pathway in EGFR-TKI resistance NSCLC.

Xiang XD, Yu J, Li GF, Xie L, Li H. Xiang XD, et al. Asian Pac J Trop Med. 2014 May;7(5):394-7. doi: 10.1016/S1995-7645(14)60063-8. Asian Pac J Trop Med. 2014. PMID: 25063068 Free article.

5

[Comparative analysis of integrated (99m)Tc-MIBI-SPECT/localizable CT and integrated ¹⁸F-FDG-PET/CT for differential diagnosis of solitary pulmonary nodules].

Deng Z, Li G, Xiang X, Jia L, Liu C, Chen T, Liu C. Deng Z, et al. Among authors: xiang x. Nan Fang Yi Ke Da Xue Xue Bao. 2015 Mar;35(3):422-6. Nan Fang Yi Ke Da Xue Xue Bao. 2015. PMID: 25818793 Chinese.

6

Everolimus inhibits the proliferation and migration of epidermal growth factor receptor-resistant lung cancer cells A549 via regulating the microRNA-4328/phosphatase and tensin homolog signaling pathway.

Xiang X, Zhuang L, Chen H, Yang X, Li H, Li G, Yu J. Xiang X, et al. Oncol Lett. 2019 Nov;18(5):5269-5276. doi: 10.3892/ol.2019.10887. Epub 2019 Sep 19. Oncol Lett. 2019. PMID: 31612036 Free PMC article.

7

Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer.

Chen N, Li G, Li H, Xiang X, Guo G, Ma Q, Zhang Y. Chen N, et al. Among authors: xiang x. Cell Mol Biol (Noisy-le-grand). 2020 Jul 31;66(5):208-213. Cell Mol Biol (Noisy-le-grand). 2020. PMID: 33040838

8

The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway.

Zhao WT, Han LX, Liu L, Zeng BZ, Zhang Y, Zhao LF, Hu HY, Xia JW, Li YZ, Xiang XD, Lin XL, Lu D, Li GF. Zhao WT, et al. J Cancer. 2021 Apr 7;12(11):3325-3334. doi: 10.7150/jca.56426. eCollection 2021. J Cancer. 2021. PMID: 33976742 Free PMC article.

9

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers.

Lei Y, Wang K, Liu Y, Wang X, Xiang X, Ning X, Ding W, Duan J, Li D, Zhao W, Li Y, Zhang F, Luo X, Shi Y, Wang Y, Huang D, Bai Y, Zhang H. Lei Y, et al. Among authors: xiang x. Front Immunol. 2022 Feb 21;13:811601. doi: 10.3389/fimmu.2022.811601. eCollection 2022. Front Immunol. 2022. PMID: 35265073 Free PMC article.

10

HNRNPA2B1-mediated m⁶A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.

Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, Zhou CY, Wang ZY, Zhuang L. Li K, et al. J Transl Med. 2023 Jun 12;21(1):382. doi: 10.1186/s12967-023-04190-8. J Transl Med. 2023. PMID: 37308993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,087 results

Search Page